Internship

Summer 2025 – Discovery Chemistry Internship

Posted on 9/19/2024

Bristol-Myers Squibb

Bristol-Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

Biotechnology
Healthcare

Boston, MA, USA

Category
Biology Lab & Research
Biology & Biotech
Requirements
  • Three years of chemistry (organic chemistry I/II required) course work at the college level, a strong academic record (≥ 3.0 GPA) and at least three semesters of laboratory course work and research
  • Self-motivated to learn and contribute, demonstrated examples of independent productivity and team-based interpersonal skills
  • Enthusiastic and curious about science, laboratory work and drug discovery
  • Prior chemistry laboratory experience in the academic setting and/or biotechnology/pharmaceutical industry
Responsibilities
  • Literature evaluation of proposed reaction routes
  • Preparation of molecules of interest through multi-step organic synthesis
  • New chemical transformation optimization
  • Purification using HPLC and other automated methods
  • Compound characterization using NMR and MS data
  • Participate and contribute during scientific discussions, meetings, and presentations
  • Apply method development to parallel library synthesis strategies for rapid implementation by medicinal chemistry project teams
  • Writing up research reports that capture experimental data and progress
  • Contribute to a research effort that may be amenable to publication or public presentation

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

Company Stage

IPO

Total Funding

$33.7B

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • BMS's collaboration with AI Proteins could lead to novel miniprotein-based therapeutics.
  • The $3.5bn agreement with Prime Medicine enhances BMS's cell and gene-therapy pipeline.
  • Karen Costello's appointment may strengthen BMS's commercial strategy in Ireland.

What critics are saying

  • BMS faces legal challenges, including a lawsuit against HRSA and HHS.
  • The dismissal of a $6.4 billion lawsuit could impact BMS's financial standing.
  • Regulatory hurdles may delay the approval of new drugs, affecting market entry.

What makes Bristol-Myers Squibb unique

  • BMS focuses on oncology, immunology, and cardiovascular diseases for innovative treatments.
  • The company invests heavily in R&D to develop new drugs and therapies.
  • BMS offers both innovative and generic medicines, increasing healthcare accessibility.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE